EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC 4.0

Electronic Patient File‐Embedded Model‐Informed Precision Dosing Compared with Physician Dosing of Tacrolimus in Kidney Transplantation

Dirk R J Kuypers iD, Pieter Annaert iD, Borefore Jallah, Maarten Naesens iD, Maxine Teuns, Annouschka Laenen iD, Ruben Faelens iD

Clinical Pharmacology & Therapeutics · 2026-02 · 119 (2) · 381-392

DOI: 10.1002/cpt.70090 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 11.10.2025. Verfasst von Dirk R J Kuypers und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Renal Transplantation, University Hospitals, Leuven, Belgium. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Immunosuppressive Agents, Electronic Health Records. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Model‐informed precision dosing (MIPD) of tacrolimus in renal allograft recipients, evaluated in silico , demonstrated improved (time to and) probability of target concentration attainment and smaller deviations from target range. Using simulated tacrolimus concentration‐time profiles, a study of 200 patients was predicted to have sufficient power to demonstrate superior performance of MIPD for these exposure end points compared with physician‐based dosing. A fully automated tacrolimus MIPD application integrated in the electronic patient file was tested in 293 de novo recipients in the first 14 days after transplantation in a prospective randomized controlled clinical validation study. More patients dosed with the MIPD application reached the primary study end point of three in‐target tacrolimus pre‐dose trough concentrations by Day 8, compared with physician‐dosed patients: 52.2% (95% CI: 45.3–59.6) vs. 35.7% (95% CI: 27.4–45.6); HR: 1.64 (95% CI: 1.10–2.43) ( P = 0.015). The mean fraction of samples per patient in target during the complete study period was higher in the MIPD arm: 0.38 ± 0.14 compared with the physician‐dosed arm: 0.28 ± 0.14 ( P < 0.001). The mean distance from target window was significantly lower in MIPD‐treated patients: 0.022 (95% CI: 0.019–0.024) vs. 0.040 (95% CI: 0.036–0.044) ( P < 0.001). On 19 occasions (< 1%), MIPD tacrolimus dose suggestions were actively overruled by physicians. A fully automated MIPD application for tacrolimus in de novo renal recipients, integrated in the electronic patient file, demonstrated superior performance in achieving tacrolimus exposure targets with limited active overruling of MIPD dose executions by physicians. Automated MIPD can be tested in larger trials to evaluate the impact of dosing decision support on clinical outcomes after renal transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationImmunosuppressive AgentsElectronic Health RecordsPhysiciansHumansMaleFemaleMiddle AgedAdultProspective StudiesDrug MonitoringComputer Simulation

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology and Renal Transplantation, University Hospitals, Leuven, Belgium.
  • Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Department of Public Health and Primary Care, Leuven Biostatistics and Statistical Bioinformatics Centre, KU Leuven, Leuven, Belgium.
  • Johnson & Johnson, Clinical Pharmacology & Pharmacometrics, Beerse, Belgium.

ORCID-Profile: Dirk R J Kuypers, Pieter Annaert, Maarten Naesens, Annouschka Laenen, Ruben Faelens

Zitieren

APA

Kuypers, D. R. J., Annaert, P., Jallah, B., Naesens, M., Teuns, M., Laenen, A., & Faelens, R. (2026). Electronic Patient File‐Embedded Model‐Informed Precision Dosing Compared with Physician Dosing of Tacrolimus in Kidney Transplantation. Clinical Pharmacology & Therapeutics, 119(2), 381-392. https://doi.org/10.1002/cpt.70090

Vancouver

Kuypers DRJ, Annaert P, Jallah B, Naesens M, Teuns M, Laenen A, et al. Electronic Patient File‐Embedded Model‐Informed Precision Dosing Compared with Physician Dosing of Tacrolimus in Kidney Transplantation. Clinical Pharmacology & Therapeutics. 2026;119(2):381-392. doi:10.1002/cpt.70090

BibTeX
@article{Kuypers2026,
  author = {Kuypers, Dirk R J and Annaert, Pieter and Jallah, Borefore and Naesens, Maarten and Teuns, Maxine and Laenen, Annouschka and Faelens, Ruben},
  title = {Electronic Patient File‐Embedded Model‐Informed Precision Dosing Compared with Physician Dosing of Tacrolimus in Kidney Transplantation},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2026},
  volume = {119},
  number = {2},
  pages = {381--392},
  doi = {10.1002/cpt.70090}
}
Kostenlos starten →